POZEN Inc (POZN.OQ)

POZN.OQ on NASDAQ Stock Exchange Global Select Market

8.10USD
17 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$8.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
100,801
52-wk High
$9.73
52-wk Low
$6.55

POZN.OQ

Chart for POZN.OQ

About

POZEN Inc. (POZEN), is a pharmaceutical company focused on transforming medicine. The Company had developed Treximet in collaboration with GlaxoSmithKline (GSK). Treximet is the brand name for the product combining sumatriptan 85 milligram, formulated with RT Technology and naproxen sodium 500 milligram in a single tablet... (more)

Overall

Beta: 2.04
Market Cap (Mil.): $259.83
Shares Outstanding (Mil.): 32.08
Dividend: 1.75
Yield (%): --

Financials

  POZN.OQ Industry Sector
P/E (TTM): 25.81 176.92 37.62
EPS (TTM): 0.31 -- --
ROI: 18.66 -0.38 17.39
ROE: 18.99 -1.43 18.30
Search Stocks

Competitors

  Price Change
Pfizer Inc. (PFE.N) $31.12 +0.45
Merck & Co., Inc. (MRK.N) $57.63 +0.83

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks